Headquarters: Rehovot, Israel
Investor Relations: Eran Rotem / 972-73-2325600 / Eran@collplant.com
CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The Company’s products are based on its recombinant human collagen produced with CollPlant’s proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing.
Exchange / Symbol